Chronic Phase Markers Market

Future Market Insights

Key Insight

The chronic phase markers market is projected to grow from USD 4.1 billion in 2025 to USD 8.6 billion by 2035, at a CAGR of 7.8%. Tumor Markers – Tumor Markers will dominate with a 25.6% market share, while hospitals and clinics will lead the end user segment with a 39.5% share.

October 09, 2025

Anurag Sharma

260 Pages

Cite this Report

Chronic Phase Markers Market

https://www.futuremarketinsights.com/reports/chronic-phase-markers-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Agilent Technologies
Becton
Bio-Rad Laboratories
T. Rowe Price
Dickinson
Illumina
Merck KGaA
PerkinElmer
QIAGEN N.V
Hoffmann-La Roche
Siemens
Sysmex Corporation
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Chronic Phase Markers Market

Key Players

Similar Industry Reports